e-learning
resources
Virtual 2021
05.09.2021
Emerging new mechanisms of chronic lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The pIgR-IgA system as a new player in lung fibrosis
T. Planté-Bordeneuve (Brussels, Belgium), C. Pilette (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), M. Lecocq (Brussels, Belgium), F. Huaux (Brussels, Belgium), A. Froidure (Brussels, Belgium)
Source:
Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Session:
Emerging new mechanisms of chronic lung disease
Session type:
E-poster
Number:
867
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Planté-Bordeneuve (Brussels, Belgium), C. Pilette (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), M. Lecocq (Brussels, Belgium), F. Huaux (Brussels, Belgium), A. Froidure (Brussels, Belgium). The pIgR-IgA system as a new player in lung fibrosis. 867
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
The pathomechanistic role of autophagy in lung fibrosis
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017
Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis
Source: Eur Respir J 2015; 46: 1084-1094
Year: 2015
Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
The role of apoptosis in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 138-144
Year: 2008
Growth factor regulation of lung fibrosis lessons from other organs
Source: Annual Congress 2006 - Scientific year in review
Year: 2006
αB-crystallin is involved in the process of pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
αB-crystallin is involved in the process of pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010
KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
The central role of CFTR in lung disease
Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?
Year: 2016
Epithelial pIgR: A new player in idiopathic pulmonary fibrosis?
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
PBI-4050 reduces expression of fibrosis biomarkers in the BioMAP SAEMyoF primary human small airway epithelial cells and lung myofibroblasts system
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Apoptosis in lung injury and fibrosis
Source: Eur Respir J 2008; 32: 1631-1638
Year: 2008
The pathogenesis of pulmonary fibrosis: a moving target
Source: Eur Respir J 2013; 41: 1207-1218
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept